{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:16:25Z","timestamp":1775546185279,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00467-018-4063-7","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T13:59:24Z","timestamp":1535032764000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study"],"prefix":"10.1007","volume":"34","author":[{"given":"Toshiyuki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6029-451X","authenticated-orcid":false,"given":"Takayuki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiko","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiaki","family":"Uetake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Ariga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"4063_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10157-016-1313-5","volume":"21","author":"K Iijima","year":"2017","unstructured":"Iijima K, Sako M, Nozu K (2017) Rituximab for nephrotic syndrome in children. Clin Exp Nephrol 21:193\u2013202. https:\/\/doi.org\/10.1007\/s10157-016-1313-5","journal-title":"Clin Exp Nephrol"},{"key":"4063_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2215\/cjn.08500815","volume":"11","author":"P Ravani","year":"2016","unstructured":"Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM (2016) Anti-CD20 antibodies for idiopathic nephrotic syndrome in children. Clin J Am Soc Nephrol 11:710\u2013720. https:\/\/doi.org\/10.2215\/cjn.08500815","journal-title":"Clin J Am Soc Nephrol"},{"key":"4063_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"AL Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guerin V, Lapillonne H, Deschenes G, Ulinski T (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2014follow-up after CD19 recovery. Nephrol Dial Transplant 27:1083\u20131089. https:\/\/doi.org\/10.1093\/ndt\/gfr405","journal-title":"Nephrol Dial Transplant"},{"key":"4063_CR4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ki.2013.211","volume":"84","author":"P Ravani","year":"2013","unstructured":"Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM (2013) Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int 84:1025\u20131033. https:\/\/doi.org\/10.1038\/ki.2013.211","journal-title":"Kidney Int"},{"key":"4063_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/s0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273\u20131281. https:\/\/doi.org\/10.1016\/s0140-6736(14)60541-9","journal-title":"Lancet"},{"key":"4063_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00467-012-2319-1","volume":"28","author":"S Ito","year":"2013","unstructured":"Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K (2013) Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome. Pediatr Nephrol 28:257\u2013264. https:\/\/doi.org\/10.1007\/s00467-012-2319-1","journal-title":"Pediatr Nephrol"},{"key":"4063_CR7","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s00467-017-3718-0","volume":"32","author":"K Kamei","year":"2017","unstructured":"Kamei K, Ishikura K, Sako M, Aya K, Tanaka R, Nozu K, Kaito H, Nakanishi K, Ohtomo Y, Miura K, Takahashi S, Morimoto T, Kubota W, Ito S, Nakamura H, Iijima K, Rituximab for Childhood-Onset Refractory Nephrotic Syndrome Study Group (2017) Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab. Pediatr Nephrol 32:2071\u20132078. https:\/\/doi.org\/10.1007\/s00467-017-3718-0","journal-title":"Pediatr Nephrol"},{"key":"4063_CR8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00467-011-1886-x","volume":"26","author":"S Ito","year":"2011","unstructured":"Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K (2011) Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:1823\u20131828. https:\/\/doi.org\/10.1007\/s00467-011-1886-x","journal-title":"Pediatr Nephrol"},{"key":"4063_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00431-012-1913-3","volume":"172","author":"S Fujinaga","year":"2013","unstructured":"Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K (2013) Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab. Eur J Pediatr 172:513\u2013518. https:\/\/doi.org\/10.1007\/s00431-012-1913-3","journal-title":"Eur J Pediatr"},{"key":"4063_CR10","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.2215\/CJN.09421010","volume":"6","author":"P Ravani","year":"2011","unstructured":"Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L, Benetti E, Scozzola F, Pasini A, Dallera N, Sica F, Belingheri M, Scolari F, Ghiggeri GM (2011) Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol 6:1308\u20131315. https:\/\/doi.org\/10.2215\/CJN.09421010","journal-title":"Clin J Am Soc Nephrol"},{"key":"4063_CR11","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207\u20132212. https:\/\/doi.org\/10.2215\/CJN.03470410","journal-title":"Clin J Am Soc Nephrol"},{"key":"4063_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1681\/ASN.2013030251","volume":"25","author":"P Ruggenenti","year":"2014","unstructured":"Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Marasa M, Chianca A, Rubis N, Ene-Iordache B, Rudnicki M, Pollastro RM, Capasso G, Pisani A, Pennesi M, Emma F, Remuzzi G, Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis Study Group (2014) Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol 25:850\u2013863. https:\/\/doi.org\/10.1681\/ASN.2013030251","journal-title":"J Am Soc Nephrol"},{"key":"4063_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1159\/000356439","volume":"38","author":"T Kimata","year":"2013","unstructured":"Kimata T, Hasui M, Kino J, Kitao T, Yamanouchi S, Tsuji S, Kaneko K (2013) Novel use of rituximab for steroid-dependent nephrotic syndrome in children. Am J Nephrol 38:483\u2013488. https:\/\/doi.org\/10.1159\/000356439","journal-title":"Am J Nephrol"},{"key":"4063_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ndt\/gfu267","volume":"30","author":"A Sinha","year":"2015","unstructured":"Sinha A, Bhatia D, Gulati A, Rawat M, Dinda AK, Hari P, Bagga A (2015) Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome. Nephrol Dial Transplant 30:96\u2013106. https:\/\/doi.org\/10.1093\/ndt\/gfu267","journal-title":"Nephrol Dial Transplant"},{"key":"4063_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00467-012-2406-3","volume":"28","author":"S Tellier","year":"2013","unstructured":"Tellier S, Brochard K, Garnier A, Bandin F, Llanas B, Guigonis V, Cailliez M, Pietrement C, Dunand O, Nathanson S, Bertholet-Thomas A, Ichay L, Decramer S (2013) Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome. Pediatr Nephrol 28:911\u2013918. https:\/\/doi.org\/10.1007\/s00467-012-2406-3","journal-title":"Pediatr Nephrol"},{"key":"4063_CR16","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","volume":"27","author":"MJ Kemper","year":"2012","unstructured":"Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dotsch J (2012) Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant 27:1910\u20131915. https:\/\/doi.org\/10.1093\/ndt\/gfr548","journal-title":"Nephrol Dial Transplant"},{"key":"4063_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1681\/asn.2015050523","volume":"27","author":"M Colucci","year":"2016","unstructured":"Colucci M, Carsetti R, Cascioli S, Casiraghi F, Perna A, Rava L, Ruggiero B, Emma F, Vivarelli M (2016) B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome. J Am Soc Nephrol 27:1811\u20131822. https:\/\/doi.org\/10.1681\/asn.2015050523","journal-title":"J Am Soc Nephrol"},{"key":"4063_CR18","doi-asserted-by":"publisher","unstructured":"(1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13:159\u2013165. https:\/\/doi.org\/10.1038\/ki.1978.23","DOI":"10.1038\/ki.1978.23"},{"key":"4063_CR19","first-page":"69","volume":"103","author":"S Nishiyama","year":"1999","unstructured":"Nishiyama S, Kiwaki K, Inomoto T, Seino Y (1999) Bone mineral density of the lumber spine and total body mass in Japanese children and adolescent. Nihon Shonika Gakkai Zasshi 103:69\u201376","journal-title":"Nihon Shonika Gakkai Zasshi"},{"key":"4063_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10157-017-1415-8","volume":"22","author":"M Sato","year":"2018","unstructured":"Sato M, Kamei K, Ogura M, Ishikura K, Ito S (2018) Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion. Clin Exp Nephrol 22:110\u2013116. https:\/\/doi.org\/10.1007\/s10157-017-1415-8","journal-title":"Clin Exp Nephrol"},{"key":"4063_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1046\/j.1328-8067.2001.01533.x","volume":"44","author":"M Honda","year":"2002","unstructured":"Honda M (2002) Nephrotic syndrome and mizoribine in children. Pediatr Int 44:210\u2013216","journal-title":"Pediatr Int"},{"key":"4063_CR22","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/ndt\/gfh996","volume":"20","author":"Y Kawasaki","year":"2005","unstructured":"Kawasaki Y, Hosoya M, Kobayashi S, Ohara S, Onishi N, Takahashi A, Isome M, Suzuki H (2005) Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome. Nephrol Dial Transplant 20:2243\u20132247. https:\/\/doi.org\/10.1093\/ndt\/gfh996","journal-title":"Nephrol Dial Transplant"},{"key":"4063_CR23","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1007\/s00467-005-2025-3","volume":"20","author":"Y Ohtomo","year":"2005","unstructured":"Ohtomo Y, Fujinaga S, Takada M, Murakami H, Akashi S, Shimizu T, Kaneko K, Yamashiro Y (2005) High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity. Pediatr Nephrol 20:1744\u20131749. https:\/\/doi.org\/10.1007\/s00467-005-2025-3","journal-title":"Pediatr Nephrol"},{"key":"4063_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00467-010-1707-7","volume":"26","author":"S Fujinaga","year":"2011","unstructured":"Fujinaga S, Hirano D, Nishizaki N, Someya T, Ohtomo Y, Ohtsuka Y, Shimizu T, Kaneko K (2011) Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration. Pediatr Nephrol 26:479\u2013483. https:\/\/doi.org\/10.1007\/s00467-010-1707-7","journal-title":"Pediatr Nephrol"},{"key":"4063_CR25","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-016-3515-9","volume":"27","author":"LM Ward","year":"2016","unstructured":"Ward LM, Konji VN, Ma J (2016) The management of osteoporosis in children. Osteoporos Int 27:2147\u20132179. https:\/\/doi.org\/10.1007\/s00198-016-3515-9","journal-title":"Osteoporos Int"},{"key":"4063_CR26","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/rheumatology\/kes003","volume":"51","author":"MG Burt","year":"2012","unstructured":"Burt MG, Willenberg VM, Petersons CJ, Smith MD, Ahern MJ, Stranks SN (2012) Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study. Rheumatology (Oxford) 51:1112\u20131119. https:\/\/doi.org\/10.1093\/rheumatology\/kes003","journal-title":"Rheumatology (Oxford)"},{"key":"4063_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3803\/EnM.2017.32.2.180","volume":"32","author":"S Suh","year":"2017","unstructured":"Suh S, Park MK (2017) Glucocorticoid-induced diabetes mellitus: an important but overlooked problem. Endocrinol Metab (Seoul, Korea) 32:180\u2013189. https:\/\/doi.org\/10.3803\/EnM.2017.32.2.180","journal-title":"Endocrinol Metab (Seoul, Korea)"},{"key":"4063_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/ndt\/gfu258","volume":"30","author":"K Kamei","year":"2015","unstructured":"Kamei K, Takahashi M, Fuyama M, Saida K, Machida H, Sato M, Ogura M, Ito S (2015) Rituximab-associated agranulocytosis in children with refractory idiopathic nephrotic syndrome: case series and review of literature. Nephrol Dial Transplant 30:91\u201396. https:\/\/doi.org\/10.1093\/ndt\/gfu258","journal-title":"Nephrol Dial Transplant"},{"key":"4063_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.15171\/jrip.2017.04","volume":"6","author":"W Cheungpasitporn","year":"2017","unstructured":"Cheungpasitporn W, Kopecky SL, Specks U, Bharucha K, Fervenza FC (2017) Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. J Renal Inj Prev 6:18\u201325. https:\/\/doi.org\/10.15171\/jrip.2017.04","journal-title":"J Renal Inj Prev"},{"issue":"mar02 1","key":"4063_CR30","doi-asserted-by":"publisher","first-page":"bcr2014208203","DOI":"10.1136\/bcr-2014-208203","volume":"2015","author":"K. H. Ng","year":"2015","unstructured":"Ng KH, Dearden C, Gruber P (2015) Rituximab-induced Takotsubo syndrome: more cardiotoxic than it appears? BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2014-208203","journal-title":"Case Reports"},{"key":"4063_CR31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00467-014-2794-7","volume":"29","author":"YH Ahn","year":"2014","unstructured":"Ahn YH, Kang HG, Lee JM, Choi HJ, Ha IS, Cheong HI (2014) Development of antirituximab antibodies in children with nephrotic syndrome. Pediatr Nephrol 29:1461\u20131464. https:\/\/doi.org\/10.1007\/s00467-014-2794-7","journal-title":"Pediatr Nephrol"},{"key":"4063_CR32","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1002\/art.23059","volume":"56","author":"E Keystone","year":"2007","unstructured":"Keystone E, Fleischmann R, Emery P, Furst DE, van Vollenhoven R, Bathon J, Dougados M, Baldassare A, Ferraccioli G, Chubick A, Udell J, Cravets MW, Agarwal S, Cooper S, Magrini F (2007) Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis Rheum 56:3896\u20133908. https:\/\/doi.org\/10.1002\/art.23059","journal-title":"Arthritis Rheum"},{"key":"4063_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/sj.ki.5002628","volume":"73","author":"FC Fervenza","year":"2008","unstructured":"Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC (2008) Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 73:117\u2013125. https:\/\/doi.org\/10.1038\/sj.ki.5002628","journal-title":"Kidney Int"},{"key":"4063_CR34","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/ard.2007.083162","volume":"67","author":"D Albert","year":"2008","unstructured":"Albert D, Dunham J, Khan S, Stansberry J, Kolasinski S, Tsai D, Pullman-Mooar S, Barnack F, Striebich C, Looney RJ, Prak ET, Kimberly R, Zhang Y, Eisenberg R (2008) Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus. Ann Rheum Dis 67:1724\u20131731. https:\/\/doi.org\/10.1136\/ard.2007.083162","journal-title":"Ann Rheum Dis"},{"key":"4063_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00467-012-2361-z","volume":"28","author":"L Delbe-Bertin","year":"2013","unstructured":"Delbe-Bertin L, Aoun B, Tudorache E, Lapillone H, Ulinski T (2013) Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome? Pediatr Nephrol 28:447\u2013451. https:\/\/doi.org\/10.1007\/s00467-012-2361-z","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-018-4063-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4063-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4063-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:23:02Z","timestamp":1659054182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-018-4063-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4063"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-4063-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]},"assertion":[{"value":"1 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Research Ethics Committee of Hokkaido University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the parents of all patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}